BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Carrying on with a Sans plastic Way of life: Individual Examinations in Maintainability - 2Dave Coulier shares new cancer diagnosis 1 year after revealing previous diagnosis
- 3Novartis eyes more bolt-on acquisitions, CEO says
- 4Judge sets $60K bond for Florida congresswoman accused of stealing $5M in COVID-19 funds
- 5Accomplishing Balance between fun and serious activities: Procedures for a Better Life
- Italy now recognizes the crime of femicide and punishes it with life in prison
- Huge Iranian missile fragments, intercepted by air defenses, lay scattered across Israel, West Bank
- 10 Famous Frozen yogurt Flavors All over The Planet
- What we know about the 'Stranger Things' spinoff — plus the one cast member who guessed it correctly
- Vote in favor of Your Fantasy Vehicle: Which Notable Model Catches Your Heart?
- Aluminum salts emerge as likely target as health officials scrutinize childhood vaccines
- 21 Incredibly Interesting Contemplations To Observe Consistently
- Reviving Your Home with Nutritious Indoor Plants
- Geminid meteors streak under green sky | Space photo of the day for Dec. 19, 2025
